Dr. Dorothee Ambrosius
Senior Advisor Biopharmaceuticals
Dorothee Ambrosius, a senior expert with over 30 years of experience in research and development of biopharmaceutical medical products, operates since 2020 as an independent Senior Advisor. The development and production of innovative biological medicine to treat unmet medical needs has been the focus of her entire industrial career. In addition to her scientific background and development knowledge, she has held numerous executive positions in 3 different global pharmaceutical companies.
Her leadership and management skills along with business sense were developed during her 17 years at Boehringer Ingelheim in various management positions, including Executive Director Downstream Development, Head CMC Strategy for Biologicals and Senior Vice President Bioprocess & Pharmaceutical Development, responsible for process development (drug substances, drug products, devices, clinical trial supplies and process transfer to operations) for biopharmaceutical products. She led a global process development organization with over 700 employees at 4 different locations in Germany, Austria, US and China.
She joined Boehringer Ingelheim in 2003 after 13 years in research. In 1989 she started her industrial career at Boehringer Mannheim in Biological Research and became a member of the Roche R&D Center for Biologics in 1997. Dorothee received her PhD in Biology from the RWTH Aachen in 1989.
She is a member of a university council, a member of various conference organizing committees, a guest lecturer at the KIT and a member of scientific advisory boards for Biotech companies.